Literature DB >> 29667253

Patient blood management, what does this actually mean for neonates and infants?

G L Crighton1,2, H V New3,4, H G Liley5,6, S J Stanworth7,8,9.   

Abstract

Patient blood management (PBM) refers to an evidence-based package of care that aims to improve patient outcomes by optimal use of transfusion therapy, including managing anaemia, preventing blood loss and improving anaemia tolerance in surgical and other patients who may need transfusion. In adults, PBM programmes are well established, yet the definition and implementation of PBM in neonates and children lags behind. Neonates and infants are frequently transfused, yet they are often under-represented in transfusion trials. Adult PBM programmes may not be directly applicable to these populations. We review the literature in neonatal (and applicable paediatric) transfusion medicine and propose specific neonatal PBM definitions and elements.
© 2018 British Blood Transfusion Society.

Entities:  

Keywords:  neonate; paediatric; patient blood management; transfusion

Mesh:

Year:  2018        PMID: 29667253     DOI: 10.1111/tme.12525

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  3 in total

1.  Embedding best transfusion practice and blood management in neonatal intensive care.

Authors:  Cindy J Flores; Anil Lakkundi; Joanne McIntosh; Peter Freeman; Amanda Thomson; Ben Saxon; Justine Parsons; Tracey Spigiel; Sarah Milton; Bryony Ross
Journal:  BMJ Open Qual       Date:  2020-01

2.  Quantification of total haemoglobin concentrations in human whole blood by spectroscopic visible-light optical coherence tomography.

Authors:  Colin Veenstra; Saskia Kruitwagen; Dafne Groener; Wilma Petersen; Wiendelt Steenbergen; Nienke Bosschaart
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

3.  Editorial: Hemostatic Challenges in Pediatric Critical Care Medicine.

Authors:  Gemma L Crighton; Oliver Karam; Marianne E Nellis; Simon J Stanworth
Journal:  Front Pediatr       Date:  2021-07-12       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.